Sars Antibody And Venipuncture

Lab Reagents

Human IgG antibody Laboratories manufactures the sars antibody and venipuncture reagents distributed by Genprice. The Sars Antibody And Venipuncture reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Sars products are available in stock. Specificity: Sars Category: Antibody Group: And Venipuncture

And Venipuncture information

SARS M antibody

10R-1977 Fitzgerald 100 ul 289.2 EUR
Description: Mouse monoclonal SARS M antibody

SARS Spike Antibody

20-abx137184 Abbexa
  • 1262.40 EUR
  • 1846.80 EUR
  • 2064.00 EUR
  • 100 ug
  • 200 ug
  • 300 µg

SARS Nucleocapsid Antibody

20-abx137185 Abbexa
  • 1262.40 EUR
  • 1846.80 EUR
  • 2364.00 EUR
  • 100 ug
  • 200 ug
  • 300 µg

SARS Spike Antibody

20-abx137200 Abbexa
  • 1412.40 EUR
  • 2264.40 EUR
  • 2665.20 EUR
  • 100 ug
  • 200 ug
  • 300 µg

SARS Nucleocapsid Antibody

20-abx137201 Abbexa
  • 1412.40 EUR
  • 2264.40 EUR
  • 2665.20 EUR
  • 100 ug
  • 200 ug
  • 300 µg

SARS-E2 Antibody

abx016055-100ul Abbexa 100 ul 493.2 EUR

SARS-M Antibody

abx016056-100ul Abbexa 100 ul 493.2 EUR

SARS Polyclonal Antibody

A53977 EpiGentek 100 µg 684.66 EUR
Description: The best epigenetics products

Anti-SARS antibody

PAab07609 Lifescience Market 100 ug 463.2 EUR

Anti-SARS antibody

STJ28816 St John's Laboratory 100 µl 332.4 EUR
Description: This gene belongs to the class II amino-acyl tRNA family. The encoded enzyme catalyzes the transfer of L-serine to tRNA (Ser) and is related to bacterial and yeast counterparts. Multiple alternatively spliced transcript variants have been described but the biological validity of all variants is unknown.

Anti-SARS antibody

STJ115313 St John's Laboratory 100 µl 332.4 EUR
Description: This gene belongs to the class II amino-acyl tRNA family. The encoded enzyme catalyzes the transfer of L-serine to tRNA (Ser) and is related to bacterial and yeast counterparts. Multiple alternatively spliced transcript variants have been described but the biological validity of all variants is unknown.

Sars/ Rat Sars ELISA Kit

ELI-41050r Lifescience Market 96 Tests 1063.2 EUR

SARS Antibody, HRP conjugated

1-CSB-PA04145B0Rb Cusabio
  • 380.40 EUR
  • 402.00 EUR
  • 100ug
  • 50ug
Description: A polyclonal antibody against SARS. Recognizes SARS from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

SARS Antibody, FITC conjugated

1-CSB-PA04145C0Rb Cusabio
  • 380.40 EUR
  • 402.00 EUR
  • 100ug
  • 50ug
Description: A polyclonal antibody against SARS. Recognizes SARS from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

SARS Antibody, Biotin conjugated

1-CSB-PA04145D0Rb Cusabio
  • 380.40 EUR
  • 402.00 EUR
  • 100ug
  • 50ug
Description: A polyclonal antibody against SARS. Recognizes SARS from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

SARS-CoV Spike Antibody

3219-002mg ProSci 0.02 mg 206.18 EUR
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody

3219-01mg ProSci 0.1 mg 523.7 EUR
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.